| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ebab93ada11c16009cf7e2829797d6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5096615470e3bcea8ee2341fd8390eef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf63f919aeb20075b2742c70987deec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba67ba94758e3692e64379aeef1364f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0659062aa04e59e552f3d633460f7e47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c321e2ea609a275b115a1757643e1d |
| publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013322120-A1 |
| titleOfInvention |
Cancer chemotherapeutic agent/formulation, manufacture and use thereof |
| abstract |
A cancer chemotherapeutic agent that is particularly kinase suppressing and/ or any other signaling pathway interfering agents and pharmaceutical formulations/ compositions involving the same and its process of manufacture is provided. A potential the cancer chemotherapeutic agent is provided which apart from stated anticancer activity as a proven kinase suppressing and/ or any other signaling pathway interfering agent could also involve specific potential binding affinity towards the intramolecular G-Quadruplex DNA structure and/ or other potential quadruplex forming sequences over duplex DNA structures favours further diverse end use and application including but not limited to antiaging, antiangiogenic, antiproliferative, antitumor, antibiotic, antiviral, antifungal and multiple anticancer therapeutics, and also possesses favourable cytotoxicity values towards uncontrollably proliferative cells by inducing apoptosis irrespective of cells' p53 status, without being cytotoxic to normal cells. |
| priorityDate |
2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |